Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

about

Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.Impact of smoking on outcome of resected lung adenocarcinoma.

P2860

Q36945837-0FDDEEA2-18B3-48B9-864F-DC642FEBE28B Q41513953-665A8F50-18E1-4A4B-B0D4-6C99E2E655E0

P2860

Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

Item

http://www.wikidata.org/entity/Q38197071

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Republished: lung cancer in ne ...... gnostics and targeted therapy?

@en

type

Item

label

Republished: lung cancer in ne ...... gnostics and targeted therapy?

@en

prefLabel

Republished: lung cancer in ne ...... gnostics and targeted therapy?

@en

P1476

Republished: lung cancer in ne ...... gnostics and targeted therapy?

@en

P2860

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Somatic mutations affect key pathways in lung adenocarcinoma

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

P304

228-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/POSTGRADMEDJ-2012-201296REP

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1062

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sai-Hong Ignatius Ou

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24643262

http://www.w3.org/2001/XMLSchema#string

Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

about

P2860

P2860

Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698